JAN 15, 2016 11:46 AM PST

Inflammation, Glutamate, and Treating Depression

WRITTEN BY: Kara Marker
While inflammation triggered by the immune system is a vital response in many cases like when pathogens invade the body, inflammation at the wrong time or too much inflammation can cause problems. Inflammation has even been identified as a potential cause of depression, and scientists from the Emory School of Medicine recently showed locating these inflammatory markers in the brain could lead them to new drug targets for certain cases of depression.
 
Elevated glutamate levels in the basal ganglia, an area of the brain devoted to motor control, motivation, and decision making, was found to be associated with depressed patients who also have systemic inflammation (Neuroscience Online). Based on this association, Emory researchers aimed to identify which depression patients would respond best to medication targeting high levels of glutamate in their new study published in Molecular Psychiatry.
 
Glutamate is the “major excitatory transmitter” in the brain, but at too-high levels it can be toxic to neurons and glia, which are needed for healthy brain function (The Neurotransporter Group). This particular study focused on glutamate levels in the basal ganglia after previous studies discovered that hepatitis C treatments stimulated inflammation, depressive symptoms, and increased glutamate in the basal ganglia.
 
“Inflammation markers can guide us to which depressed patients respond best to glutamate blockers," lead author Ebrahim Haroon, MD, said about the study. "This could be an important step toward personalizing treatment for depression."
 
Glutamate and depression

Haroon and his team looked at 50 patients with depression not currently receiving antidepressant treatment. They looked for C-reactive protein (CRP) prevalence in the blood stream, a marker of inflammation since protein levels, produced by the liver, rise when there is inflammation in the body (MedlinePlus). They also measured glutamate levels in the basal ganglia using magnetic resonance spectroscopy (MRS) and myo-inositol, a marker for glial health.
 
Indeed, their results showed slow motor function, measured by finger tapping speed, and anhedonia, the inability to feel pleasure and a common characteristic of depression, coincided with high levels of glutamate and myo-inositol in the basal ganglia.
 
This study provides new insight into how individualizing depression treatments can make controlling and limiting the disease much easier. The next challenge for researchers devoted to the connection between inflammation, glutamate, and depression will be to reduce depression-causing inflammation without dampening the power of the immune system to fight disease.
 
For more on treating depression in patients with high levels of glutamate, check out the following video.
 
 
 
Source: Emory Health Sciences
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 22, 2020
Cardiology
A New 3D Imaging Method for Atherosclerosis Analysis in Mice
DEC 22, 2020
A New 3D Imaging Method for Atherosclerosis Analysis in Mice
Imaging in research may not sound glamorous, but how else would news stories get those cool looking science photos for t ...
JAN 03, 2021
Microbiology
Flu Season is Off to a Very Slow Start
JAN 03, 2021
Flu Season is Off to a Very Slow Start
The flu season would have typically been well underway by mid-December in a normal year. But this year, there are few ca ...
JAN 06, 2021
Immunology
What's Causing Prostate Cancer Patients to Doze Off?
JAN 06, 2021
What's Causing Prostate Cancer Patients to Doze Off?
For prostate cancer patients, androgen deprivation therapy or ADT is a standard treatment aimed at stalling the growth o ...
JAN 07, 2021
Clinical & Molecular DX
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
JAN 07, 2021
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
Cardiovascular disease is the leading cause of death worldwide, taking nearly 18 million lives every year. Of these card ...
JAN 18, 2021
Microbiology
Bacteria in Sediment is Likely Accelerating Greenland's Meltdown
JAN 18, 2021
Bacteria in Sediment is Likely Accelerating Greenland's Meltdown
For decades, scientists have been sounding the alarm about rising carbon dioxide levels in our planet's atmosphere, and ...
JAN 21, 2021
Health & Medicine
Injectable Cannabis Overdose Drug Being Developed
JAN 21, 2021
Injectable Cannabis Overdose Drug Being Developed
It’s estimated that the number of visits to emergency rooms because of cannabis overdose tripled between 2011 and ...
Loading Comments...